Risk Factors for Rescue Therapy in Crohn's Patients on Combination Therapy After Discontinuation of the Immunomodulator

被引:0
|
作者
Fischer, Monika
Campbell, Sarah C.
Johnson, Cynthia S.
Helper, Debra J.
Chiorean, Michael V.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1373
引用
收藏
页码:S450 / S450
页数:1
相关论文
共 50 条
  • [41] Predictors and Outcomes of Requiring Change of Therapy to Risankizumab, Upadacitnib, or Combination Therapy in Patients with Crohn's Disease
    Waghela, Rajdeepsingh
    Amini, Shayan
    Thurston, Theresa
    Irani, Malcolm
    Glassner, Kerri
    Abraham, Bincy P.
    Fan, Christopher
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1006 - S1007
  • [42] Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty
    Tay, GS
    Binion, DG
    Eastwood, D
    Otterson, MF
    SURGERY, 2003, 134 (04) : 565 - 572
  • [43] Combination therapy with methotrexate in paediatric Crohn's disease
    Kotsiliti, Eleni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2023, 20 (06) : 344 - 344
  • [44] Combination therapy with methotrexate in paediatric Crohn’s disease
    Eleni Kotsiliti
    Nature Reviews Gastroenterology & Hepatology, 2023, 20 : 344 - 344
  • [45] Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
    Gelber, Allan C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11): : 1086 - 1086
  • [46] Initial combination therapy in early Crohn's disease
    Sandborn, William J.
    LANCET, 2008, 371 (9613): : 635 - 636
  • [47] EARLY ANTI-TNF/IMMUNOMODULATOR THERAPY IS ASSOCIATED WITH BETTER CLINICAL OUTCOMES IN ASIAN PATIENTS WITH CROHN'S DISEASE WITH POOR PROGNOSTIC FACTORS
    Oh, Eun Hye
    Oh, Kyunghwan
    Seo, Hyungil
    Chang, Kiju
    Kim, Gwang-un
    Song, Eun Mi
    Seo, Myeongsook
    Lee, Ho-Su
    Kwon, Eun Ja
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Kim, Kyung-Jo
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Ye, Byong Duk
    GASTROENTEROLOGY, 2017, 152 (05) : S26 - S27
  • [48] Improved peri-operative surgical outcome in Crohn's disease patients receiving concomitant immunomodulator therapy
    Tay, GS
    Otterson, MF
    Binion, DG
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S261 - S261
  • [49] Increased Risk of Malignancy With Adalimumab Combination Therapy, Compared With Monotherapy, for Crohn's Disease
    Osterman, Mark T.
    Sandborn, William J.
    Colombel, Jean-Frederic
    Robinson, Anne M.
    Lau, Winnie
    Huang, Bidan
    Pollack, Paul F.
    Thakkar, Roopal B.
    Lewis, James D.
    GASTROENTEROLOGY, 2014, 146 (04) : 941 - U464
  • [50] Early anti-TNF/immunomodulator therapy is associated with better clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors
    Oh, E. H.
    Oh, K.
    Seo, H.
    Chang, K.
    Kim, G. -U.
    Song, E. M.
    Seo, M.
    Lee, H. -S.
    Kwon, E. J.
    Hwang, S. W.
    Park, S. H.
    Yang, D. -H.
    Kim, K. -J.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S324 - S324